COMMUNIQUÉS West-GlobeNewswire

Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés
23/07/2026
Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés Ces dirigeants expérimentés du secteur apportent plusieurs décennies d’expertise en stratégie commerciale, services aux [...]
Egg Medical annonce une nouvelle ère dans la sécurité en salle de fluoroscopie à la suite d’une déclaration de consensus conjointe
23/07/2026
Tandis que les principales sociétés médicales demandent l’adoption obligatoire de dispositifs de protection contre les rayonnements (ERPD), le système EggNest® Complete s’impose comme la solution définitive de [...]
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
23/07/2026
BASEL, Switzerland and LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026, to [...]
Crescent Biopharma Announces Grants of Inducement Awards
23/07/2026
WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
23/07/2026
DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT ) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the [...]
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
23/07/2026
Media Release COPENHAGEN, Denmark and NORTH CHICAGO, Ill.; July 23, 2026 Genmab and AbbVie clarify overall survival (OS) was the sole U.S. primary endpoint in the Phase 3 EPCORE ® DLBCL-1 trial and was not met Genmab A/ [...]
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
23/07/2026
MINNEAPOLIS, July 23, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
23/07/2026
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 28, 2026 at 8:30 a.m. Eastern [...]
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
23/07/2026
WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
23/07/2026
Interim Phase 1 results accepted for poster presentation at ESMO Congress 2026 Achieved pre-specified Stage 1 response threshold in squamous cell carcinoma of the head and neck (SCCHN) cohort and enrolling Stage 2 per [...]
Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
23/07/2026
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended June 30, 2026 [...]
OKYO Pharma Announces Purchase of Shares by Director
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
23/07/2026
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global [...]
Affidea accelerates its UK growth through strategic partnership with LIPS Healthcare
23/07/2026
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Affidea, the pan-European provider of community-based clinics, advanced diagnostics, and specialist private healthcare services, today announces a strategic partnership with [...]
Guerbet : H1 2026 revenue.
23/07/2026
H1 2026 revenue H1 activity Revenue of €379.2m at 30 June 2026, nearly stable at CER 1 and on a like-for-like basis 2 (-0.1%) A 2.5% decline in Q2 at CER and on a like-for-like basis, marked by a solid recovery in the [...]
Atos achieves CMMC 2.0 Level 2 certification, strengthening readiness for mission-critical and complex defense programs
23/07/2026
Irving, Texas, USA – July 23, 2026 – Atos IT Solutions and Services Inc. has achieved Cybersecurity Maturity Model Certification (CMMC) 2.0 Level 2 for its North America Managed Detection & Response (MDR) Security [...]
Serotonin Centers Expands into Greater San Diego with New Del Mar Location
23/07/2026
Physician-Led Longevity Brand Brings Hormone Optimization, Medical Weight Loss, Peptide Therapy and Advanced Recovery Services to One of the Nation’s Most Health-Conscious Markets SAN DIEGO, July 23, 2026 (GLOBE [...]
Guerbet : Chiffre d’affaires du 1er semestre 2026.
23/07/2026
Chiffre d’affaires du 1 er semestre 2026 Activité semestrielle Chiffre d’affaires au 30 juin 2026 de 379,2 M€, quasiment stable à TCC 1 et périmètre comparable 2 (-0,1%) Au deuxième trimestre, un repli de 2,5% à TCC et [...]
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23/07/2026
Idorsia will publish its Half Year 2026 Financial Reporting on Thursday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date: Thursday, July 30, 2026 [...]

Pages